Skip to main content

GOLDMAN SACHS GROUP INC

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 886982 NEW YORK, NY

Position in KPTI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$13,918,908
+$8,640,893 QoQ
Shares Held
1,424,658
+50.3% QoQ
Ownership
6.28%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 96 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KPTI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. KPTI ranks #142 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KPTI

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,918,908 1,424,658
2026-03-31 $5,278,015 947,579
2025-09-30 $162,747 24,885
2025-06-30 $471,531 109,404
2025-03-31 $319,433 85,410
2024-12-31 $902,981 1,335,771
2024-09-30 $1,109,473 1,336,715
2024-06-30 $1,988,095 2,290,434
2024-03-31 $2,277,474 1,508,262
2023-12-31 $1,121,552 1,296,593
2023-09-30 $2,566,162 1,915,047
2023-06-30 $2,901,623 1,621,019
2023-03-31 $5,714,981 1,469,147
2022-12-31 $3,592,552 1,056,633
2022-09-30 $7,399,260 1,355,176
2022-06-30 $6,523,272 1,446,402
2022-03-31 $6,624,936 898,906
2021-12-31 $6,615,711 1,028,882
2021-09-30 $5,734,922 985,382
2021-06-30 $10,379,040 1,005,721
2021-03-31 $12,749,933 1,211,971
2020-12-31 $16,327,714 1,054,762
2020-09-30 $12,624,298 864,678
2020-06-30 $37,881,477 2,000,078
2020-03-31 $18,427,211 959,251